艾森股份：10月24日召开董事会会议

Group 1 - The company Aisen Co., Ltd. (SH 688720) announced that its third board meeting for the year 2025 was held on October 24, 2025, to review the proposal for the company's Q3 2025 report [1] - As of the report date, Aisen Co., Ltd. has a market capitalization of 4.3 billion yuan [2] Group 2 - The Chinese innovative drug sector has generated $80 billion in overseas licensing deals this year, indicating a robust performance in the biopharmaceutical secondary market [2] - Despite the strong performance in the secondary market, the primary market for fundraising in the biopharmaceutical sector is experiencing a cooling trend [2]